Form 4 for DCOY Decoy Therapeutics Inc.
Accepted 2026-09-02 17:39:18 ET · period of report 2026-08-31 · accession 0002148287-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-02 17:39 | 2026-08-31 | DCOY | Gauthier Patricia G. | Dir | A - Grant | $0.00 | +2,000 | 2,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-31 | A | A | 2,000 | $0.00 | 2,000 | D | — | — | (F1) Restricted stock granted under the Decoy Therapeutics Inc. 2026 Equity Incentive Plan, 100 percent will vest on August 30, 2027. |